Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. Co.'s product portfolio are: ENROUTE Transcarotid Neuroprotection System, which is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, which is a self-expanding, self-tapering stent that conforms to patient; ENHANCE Transcarotid Peripheral Access Kit, which is used in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire, which is used for navigating and crossing the target lesion for delivery of interventional devices. The SILK stock yearly return is shown above.
The yearly return on the SILK stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SILK annual return calculation with any dividends reinvested as applicable (on ex-dates).
|